Showing results (151-160 of 173) with videos related to
Sort By:
Pageof 18
Obesity (Silver Spring, Md.)|August 22, 2024
GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apneaCliona O'Donnell, Odhrán Ryan, Andrew E Hogan, et al.Annals of the American Thoracic Society|December 14, 2023
Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept StudyCliona O'Donnell, Shane Crilly, Anne O'Mahony, et al.The European Respiratory Journal|April 21, 2017
Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammationAoife M Murphy, Amandine Thomas, Sophie J Crinion, et al.Journal of Sleep Research|May 19, 2016
Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort studyOreste Marrone, Salvatore Battaglia, Paschalis Steiropoulos, et al.Chest|May 17, 2014
Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) studyBrian D Kent, Ludger Grote, Silke Ryan, et al.Journal of Hypertension|October 8, 2020
Superior hypertension control with betablockade in the European Sleep Apnea DatabaseSven Svedmyr, Jan Hedner, Ding Zou, et al.Stroke|December 4, 2020
Impact of Sleep Apnea on Cardioembolic Risk in Patients With Atrial Fibrillation: Data From the ESADA CohortMartino F Pengo, Andrea Faini, Ludger Grote, et al.Journal of Sleep Research|July 28, 2025
Effect of Liraglutide on Intermittent Hypoxia-Induced Metabolic Dysfunction: From Bench to BedsideCliona O'Donnell, Ailbhe King, Guillaume Vial, et al.Journal of Sleep Research|May 26, 2018
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohortOzen K Basoglu, Ding Zou, Mehmet S Tasbakan, et al.The European Respiratory Journal|April 9, 2020
Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approachesSilke Ryan, Eoin P Cummins, Ramon Farre, et al.Pageof 18